The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 03, 2015

Filed:

Feb. 10, 2014
Applicant:

Smith & Nephew, Inc., Memphis, TN (US);

Inventors:

Eric Rolland, Divonne les bains, FR;

Thomas Hunziker, Oberhofen, CH;

Beatrice Chevallay, Lugrin, FR;

Christopher Rinsch, Morges, CH;

Assignee:

Smith & Nephew, Inc., Memphis, TN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/36 (2015.01); C12N 5/00 (2006.01); A61K 38/18 (2006.01); A61K 38/36 (2006.01); A61K 38/48 (2006.01); A61L 15/40 (2006.01); A61L 26/00 (2006.01); A61L 27/36 (2006.01); A61L 27/38 (2006.01); C12N 5/077 (2010.01); C12N 5/071 (2010.01); A61K 38/19 (2006.01); A61K 9/00 (2006.01); A61K 41/00 (2006.01); A61K 47/10 (2006.01); A61K 9/10 (2006.01); A61K 9/19 (2006.01); A61K 35/33 (2015.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/36 (2013.01); A61K 9/0014 (2013.01); A61K 9/10 (2013.01); A61K 9/19 (2013.01); A61K 35/33 (2013.01); A61K 38/18 (2013.01); A61K 38/19 (2013.01); A61K 38/363 (2013.01); A61K 38/4833 (2013.01); A61K 41/0023 (2013.01); A61K 47/10 (2013.01); A61L 15/40 (2013.01); A61L 26/0057 (2013.01); A61L 27/3616 (2013.01); A61L 27/3633 (2013.01); A61L 27/3804 (2013.01); A61L 27/3813 (2013.01); A61L 27/3886 (2013.01); C12N 5/0656 (2013.01); C12N 5/0698 (2013.01); A61K 48/00 (2013.01); C12N 2502/094 (2013.01); C12N 2502/1323 (2013.01); C12N 2510/00 (2013.01); C12N 2510/04 (2013.01);
Abstract

A kit is disclosed that includes a first component comprising alginate, wherein the first component is comprised in a first sterile vile, and a second component comprising cells comprising keratinocytes or fibroblasts, or mixtures thereof, that secrete one or more biologically active molecules selected from the group consisting of GM-CSF, VEGF, KGF, bFGF, TGFβ, angiopoietin, EGF, IL-Iβ, TGFα, and TNFα, wherein the cells are allogeneic and mitotically inactive, a buffered solution, and human serum albumin or a cryoprotectant, wherein the second component is comprised in a second vial.


Find Patent Forward Citations

Loading…